Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

Overall, 72% of 36,949 infants were immunized in the 2023-2024 RSV season with either the bivalent RSV prefusion F protein ...

Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future pandemic preparedness.

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns among medical experts.

Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1 ...

Yet blue states, where more people got COVID vaccines of their own volition, reported significantly lower rates of COVID mortality. But in both cases, neither group learned from the other’s ...

The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the newer mRNA vaccines from Pfizer/BioNTech and Moderna, has been subject to emergency use authorization ...

Nearly a year and a half after Covid vaccines ... has authorized two vaccines for children aged 6 months to 5 years old. Both vaccines are mRNA based, made by Moderna and Pfizer.

As regards its COVID products, Pfizer records direct sales and alliance revenues from its partner, BioNTech BNTX for the COVID-19 vaccine, Comirnaty. Revenues from Pfizer’s COVID vaccine ...

The COVID vaccines used in the U.S. train the body to recognize the tell-tale spike protein on the SARS-CoV-2 virus. Unlike the Pfizer and Moderna vaccines, which rely on a genetic code to trigger ...

Pfizer's PFE non-COVID operational revenues improved in 2024 ... the United States can hurt Vyndaqel’s growth. Sales of key vaccine, Prevnar, are likely to have declined due to competitive ...

April 25 is the switch day from trivalent to bivalent oral polio vaccine for Bhutan Health: The health ministry will be switching from trivalent to bivalent oral polio vaccine from today as part of ...